Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Extrapyramidal symptoms and oestrogen.

K N Thompson1, J Kulkarni, A A Sergejew

  • 1Monash University Research Centre for Women's Mental Health, Dandenong Area Mental Health Service, Victoria, Australia.

Acta Psychiatrica Scandinavica
|March 8, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Loneliness in the workplace: a mixed-method systematic review and meta-analysis.

Occupational medicine (Oxford, England)·2024
Same author

Subjective cognitive changes following premenopausal risk-reducing bilateral salpingo-oophorectomy.

Climacteric : the journal of the International Menopause Society·2023
Same author

Depression, anxiety and PTSD symptoms before and during the COVID-19 pandemic in the UK.

Psychological medicine·2022
Same author

Lipid nanoparticle formulations for optimal RNA-based topical delivery to murine airways.

European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences·2022
Same author

Bazedoxifene - a promising brain active SERM that crosses the blood brain barrier and enhances spatial memory.

Psychoneuroendocrinology·2020
Same author

Improvement in depression with oestrogen treatment in women with schizophrenia.

Archives of women's mental health·2019
Same journal

The Prevalence of Obstructive Sleep Apnoea in Schizophrenia, Bipolar Disorder and Major Depressive Disorder: A Systematic Review With Meta-Analysis.

Acta psychiatrica Scandinavica·2026
Same journal

Use of Glucagon-Like Peptide 1 Receptor Agonists and the Associated Risk of Hospitalisation in Bipolar Disorder, From a Nationwide Cohort, 2009-2024.

Acta psychiatrica Scandinavica·2026
Same journal

Benzodiazepine Use and Mortality Risk: A Nationwide Cohort Study on New Benzodiazepine Users With a 5-Year Follow-Up.

Acta psychiatrica Scandinavica·2026
Same journal

Leveraging Family Genetic Risk Scores to Understand the Etiology of Suicidal Behaviors and Their Associations With Psychiatric Disorders.

Acta psychiatrica Scandinavica·2026
Same journal

Does the Loss of Autobiographical Memories Contribute to the Therapeutic Effect of Electroconvulsive Therapy?

Acta psychiatrica Scandinavica·2026
Same journal

Electroconvulsive Therapy and Time to Psychiatric Readmission in Schizophrenia.

Acta psychiatrica Scandinavica·2026
See all related articles

High estrogen levels may reduce hyperkinetic symptoms in women with psychosis, contrary to the estrogen hypothesis. This effect is enhanced when both estrogen and progesterone are elevated.

Area of Science:

  • Neuroscience
  • Psychiatry
  • Endocrinology

Background:

  • The estrogen hypothesis suggests estrogen exacerbates neuroleptic side effects.
  • Understanding sex steroid influence on psychosis treatment is crucial.

Purpose of the Study:

  • To investigate neuroleptic side-effect severity in women with psychosis.
  • To explore associations between sex steroids and side effects across the menstrual cycle.

Main Methods:

  • Twenty-five women with psychosis were assessed.
  • Utilized the Extrapyramidal Symptom Rating Scale (ESRS) and blood hormone analysis.
  • Employed a randomized cross-over design with testing conducted twice, two weeks apart.

Main Results:

Related Experiment Videos

  • Contrary to the hypothesis, high estrogen levels were found to reduce hyperkinetic symptoms.
  • This symptom reduction was further potentiated by high levels of both estrogen and progesterone.

    • Conclusions:

    • Estrogen demonstrates a potentially beneficial role in managing hyperkinetic symptoms in psychotic women.
    • Findings suggest distinct effects of estrogen on dopamine pathways (mesolimbic vs. mesostriatal).